These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission. Gosmanov AR; Smiley D; Robalino G; Siqueira JM; Peng L; Kitabchi AE; Umpierrez GE Diabetes Care; 2010 Apr; 33(4):854-60. PubMed ID: 20067967 [TBL] [Abstract][Full Text] [Related]
3. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Mauvais-Jarvis F; Sobngwi E; Porcher R; Riveline JP; Kevorkian JP; Vaisse C; Charpentier G; Guillausseau PJ; Vexiau P; Gautier JF Diabetes; 2004 Mar; 53(3):645-53. PubMed ID: 14988248 [TBL] [Abstract][Full Text] [Related]
4. Should diabetic ketosis without acidosis be included in ketosis-prone type 2 diabetes mellitus? Xie XJ; Hu Y; Cheng C; Feng TT; He K; Mao XM Diabetes Metab Res Rev; 2014 Jan; 30(1):54-9. PubMed ID: 24038858 [TBL] [Abstract][Full Text] [Related]
8. Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640. Heneberg P Diabetes Care; 2019 May; 42(5):e81. PubMed ID: 31010949 [No Abstract] [Full Text] [Related]
9. Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640. Mulukutla SN; Acevedo-Calado M; Hampe CS; Pietropaolo M; Balasubramanyam A Diabetes Care; 2019 May; 42(5):e82-e83. PubMed ID: 31010950 [No Abstract] [Full Text] [Related]
10. Improving Ketosis-Prone Type 2 Diabetes Diagnosis in Africa. Álvarez-Aldana D MEDICC Rev; 2021; 23(3-4):61-62. PubMed ID: 34516538 [No Abstract] [Full Text] [Related]
11. Ketosis prone diabetes presenting as fulminant type 1 diabetes. Krompa K; Barka I; Malard S; Tatulashvili S; Baudry C; Bihan H; Fysekidis M Pan Afr Med J; 2018; 31():38. PubMed ID: 30918564 [TBL] [Abstract][Full Text] [Related]
13. Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes. Gupta P; Liu Y; Lapointe M; Yotsapon T; Sarat S; Cianflone K Diabet Med; 2015 May; 32(5):692-700. PubMed ID: 25407468 [TBL] [Abstract][Full Text] [Related]
14. [Study of acute inaugural ketosis-prone diabetes in a Hospital in Central-Eastern Tunisian]. Taieb A; Cheikh AB; Hasni Y; Maaroufi A; Kacem M; Chaieb M; Ach K Pan Afr Med J; 2018; 31():134. PubMed ID: 31037194 [TBL] [Abstract][Full Text] [Related]
15. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Lontchi-Yimagou E; Nguewa JL; Assah F; Noubiap JJ; Boudou P; Djahmeni E; Balti EV; Atogho-Tiedeu B; Gautier JF; Mbanya JC; Sobngwi E Diabet Med; 2017 Mar; 34(3):426-431. PubMed ID: 27657549 [TBL] [Abstract][Full Text] [Related]
17. Elevated unmethylated and methylated insulin DNA are unique markers of A+β+ ketosis prone diabetes. Mulukutla SN; Tersey SA; Hampe CS; Mirmira RG; Balasubramanyam A J Diabetes Complications; 2018 Feb; 32(2):193-195. PubMed ID: 29175121 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneous clinical features of ketosis-prone type 2 diabetes mellitus patients: gender, age, loss of weight and HbA1c. Wang J; Zhang M; Liu Z; Wang X; Pang Y; Lu Y; Liu Z Minerva Endocrinol; 2019 Dec; 44(4):351-356. PubMed ID: 30482009 [TBL] [Abstract][Full Text] [Related]
19. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Umpierrez GE Diabetes Care; 2006 Dec; 29(12):2755-7. PubMed ID: 17130220 [No Abstract] [Full Text] [Related]
20. Ketosis-prone diabetes--a new subgroup of patients with atypical type 1 and type 2 diabetes? Kitabchi AE J Clin Endocrinol Metab; 2003 Nov; 88(11):5087-9. PubMed ID: 14602730 [No Abstract] [Full Text] [Related] [Next] [New Search]